CompaniesHangzhou Adcoris Biopharmacy

Hangzhou Adcoris Biopharmacy

active
Hangzhou, China
Website
About

Bioconjugate Therapies, Antibodies, ADCs

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyChina
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

113

By Phase

PHASE1: 2

By Status

RECRUITING: 1ENROLLING_BY_INVITATION: 1

Recent Trials

NCT06238401Lead Sponsor
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
PHASE1Recruiting
77 participants
Started: Oct 29, 2024 · Completed: Jan 1, 2026
NCT05423977Lead Sponsor
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
PHASE1Enrolling by invitation
36 participants
Started: Dec 17, 2021 · Completed: Jul 7, 2026
Locations (1)
Headquarters
Hangzhou, China
Map

Loading map...